Compare CSIS WARRANT SERIES I (CSIS-W) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CSIS WARRANT SERIES I vs Merck Tbk. — how do they compare? CSIS WARRANT SERIES I trades at Rp86 (market cap 4.6B, 100 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 21.9K 24h volume). The key difference: Merck Tbk. is far larger — about 369.6× CSIS WARRANT SERIES I's market cap, and Merck Tbk. is more actively traded (21.9K versus 100). Which is the better fit depends on your goals.
| CSIS-W | MERK | |
|---|---|---|
Market Cap | 4.6B | 1.7T |
Volume | 100 | 21.9K |
Lot | 1 | 219 |
Turnover | 8.6K | 83.99M |
Average Price | 86 | 3,834.93 |
Value | 8.6K | 83.99M |
Indicative Equilibrium Price | — | 3,850 |
Indicative Equilibrium Volume | — | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CSIS WARRANT SERIES I
PT Cahayasakti Investindo Sukses Tbk (the Company) was established based on the Deed of Notary Djurnawati Soetarmono, SH, No. 52 dated June 2, 1995. The Company belongs to a group of companies owned by PT Andalan Utama Bintara.
Read more on CSIS-W →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
